Chemo Brain? Exercise, Ibuprofen Show Promise

Cognitive issues, commonly known as "chemo brain," can significantly impact memory and concentration for up to 80% of individuals undergoing chemotherapy. A phase 2 trial conducted at the University of Rochester investigated the effectiveness of exercise and low-dose ibuprofen in mitigating these effects in 86 adult cancer patients in New York.

The six-week study involved four groups, testing home-based exercise programs and 200 milligrams of ibuprofen twice daily, individually and in combination. The results indicated that exercise was linked to the most substantial improvements in attention and overall cognitive function.

Patients who combined exercise with a placebo also showed better attention compared to the placebo-only group. While participants taking ibuprofen alone also experienced cognitive gains, these were less pronounced and consistent than those observed with exercise, suggesting inflammation might play a role.

Researchers noted the trial's limitations, including its small sample size and short duration, and that findings may not apply to all patient demographics due to the high proportion of female participants. Larger phase 3 trials are planned to further validate these encouraging findings, with participants advised to consult their oncology team before starting any new interventions.